Replay, a new gene therapy business, just introduced Telaria as their newest venture. Recessive dystrophic epidermolysis bullosa is a rare skin condition for which Telaria is developing a gene treatment.
The FDA has approved a medication from Provention Bio as the first therapy to postpone the start of the most severe form of diabetes.
Recently, care.ai, a Florida-based AI-driven platform, has raised funding worth $27 million in a series led by investment firm Crescent Cove Advisors.
Replay, a new gene therapy business, just introduced Telaria as their newest venture. Recessive dystrophic epidermolysis bullosa is a rare skin condition for which Telaria is developing a gene treatment.
The FDA has approved a medication from Provention Bio as the first therapy to postpone the start of the most severe form of diabetes.
Recently, care.ai, a Florida-based AI-driven platform, has raised funding worth $27 million in a series led by investment firm Crescent Cove Advisors.
According to Business Wire, global Healthcare Industry will be worth $12T by 2022. Healthcare is vast and highly fragmented with a mix of public and private players. It comprises patients and healthcare providers such as hospitals, pharmaceuticals, and related life sciences.
Digitisation and Post-Covid world are set to transform the healthcare industry in the coming decade. Our weekly business newsletter covers innovations and disruptions in the Healthcare industry with global coverage.
HealthGeniuses is managed by IndustryGeniuses (A place where industries meet innovation). We are rolling out content platforms for the world’s hottest industries such as Food & Grocery Retail, Consumer Goods and Healthcare. For each of these key industries, we support Tech Startups and Industry Disruptors as they roll out next generation digital initiatives.
IndustryGeniuses team brings practical domain knowledge of working with 300+ tech startups and brands over the past decade.